Rights and permissions
About this article
Cite this article
CNS drugs prominent in NZ's Q2 new drug listings. Pharmacoecon. Outcomes News 317, 11 (2001). https://doi.org/10.1007/BF03269405
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269405